Abdiel Capital Advisors Lp Lowers stake in Proto Labs Inc (PRLB)

Proto Labs Inc (PRLB) : Abdiel Capital Advisors Lp reduced its stake in Proto Labs Inc by 0.01% during the most recent quarter end. The investment management company now holds a total of 794,497 shares of Proto Labs Inc which is valued at $48.4 Million after selling 48 shares in Proto Labs Inc , the firm said in a disclosure report filed with the SEC on May 12, 2016.Proto Labs Inc makes up approximately 23.52% of Abdiel Capital Advisors Lp’s portfolio.

Other Hedge Funds, Including , Canada Pension Plan Investment Board added PRLB to its portfolio by purchasing 300 company shares during the most recent quarter which is valued at $18,282.Manufacturers Life Insurance Company The boosted its stake in PRLB in the latest quarter, The investment management firm added 28,635 additional shares and now holds a total of 117,526 shares of Proto Labs Inc which is valued at $7.2 Million. Proto Labs Inc makes up approx 0.01% of Manufacturers Life Insurance Company The’s portfolio.Partnervest Advisory Services boosted its stake in PRLB in the latest quarter, The investment management firm added 8 additional shares and now holds a total of 4,053 shares of Proto Labs Inc which is valued at $242,329. Proto Labs Inc makes up approx 0.14% of Partnervest Advisory Services’s portfolio.Parkside Financial Bank Trust reduced its stake in PRLB by selling 57 shares or 3.11% in the most recent quarter. The Hedge Fund company now holds 1,776 shares of PRLB which is valued at $106,187. Proto Labs Inc makes up approx 0.05% of Parkside Financial Bank Trust’s portfolio.Bender Robert Associates reduced its stake in PRLB by selling 390 shares or 1.18% in the most recent quarter. The Hedge Fund company now holds 32,777 shares of PRLB which is valued at $2 Million. Proto Labs Inc makes up approx 1.36% of Bender Robert Associates’s portfolio.

Proto Labs Inc opened for trading at $60.19 and hit $61.3982 on the upside on Friday, eventually ending the session at $60.63, with a gain of 0.95% or 0.57 points. The heightened volatility saw the trading volume jump to 1,16,294 shares. Company has a market cap of $1,598 M.

On the company’s financial health, Proto Labs Inc reported $0.44 EPS for the quarter, missing the analyst consensus estimate by $ -0.02 based on the information available during the earnings call on Apr 28, 2016. Analyst had a consensus of $0.46. The company had revenue of $72.60 million for the quarter, compared to analysts expectations of $74.29 million. The company’s revenue was up 24.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 EPS.

Many Wall Street Analysts have commented on Proto Labs Inc. FBR Capital Initiated Proto Labs Inc on May 11, 2016 to “Outperform”, Price Target of the shares are set at $80.

Proto Labs Inc. (Proto Labs) is an online manufacturer of custom parts for prototyping and short-run production. The Company utilizes computer numerical control (CNC) machining and injection molding to manufacture custom parts for its customers. The Company provides parts for product developers and engineers across the world. The Company utilizes computer numerical control (CNC) machining and injection molding to manufacture custom parts for its customers. The Company targets its products to the product developers and engineers who use three-dimensional computer-aided design (3D CAD) software to design products across a diverse range of end-markets. Its primary manufacturing product lines include Protomold which is an injection molding product line Firstcut which is a CNC machining product line and Fineline which is an additive-manufactured (3D printing) product line. The Company has operations in the United States Europe and Japan.

Leave a Reply

Proto Labs Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Proto Labs Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.